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Prosthetic graft infection following conventional open aneurysm repair is an uncommon event. Stent graft devices for
endovascular aneurysm repair are packaged within a sterile sheath delivery system, thereby shielded from potential
contamination at the time of implantation. Thus, these devices are theoretically less susceptible to prosthetic infection. We
report a case of stent graft infection and report a systematic review of literature to evaluate the current knowledge of this
problem, with emphasis on the source of stent graft infection, bacteriology results and current treatment preferences.
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Introduction
Graft infection is an unusual but well recognized
complications of conventional open repair of abdomi-
nal aortic aneurysms (AAA), with a reported inci-
dence of about 0.4–4%,1 – 3 and a high mortality.2,4 – 6
Since the introduction of endoluminal grafting for
AAA in 1991, this technique has been enthusiastically
accepted and used with rapidly increasing frequency
in recent years. Commercially manufactured devices
are packaged within a sterile sheath delivery system,
thereby shielding the graft material from potential
contamination at the time of implantation. Thus, it
might be thought that these devices are less suscep-
tible to infection than conventionally placed aortic
grafts, even though they are inserted through the
groin, which is a potentially contaminated site.
However, there are an increasing number of reports
concerning the infection of endoluminal grafts.
We describe a patient with an infected aortic
endoluminal prosthesis as a result of Serratia marces-
cens and who was transferred to our vascular unit
following unsuccessful antibiotic treatment at another
hospital.
Case Report
In March 1998, a 68-year-old man (weight 78 kg, height
178 cm) with a 5 cm AAA extending to both proximal
iliac arteries underwent endovascular aneurysm
repair in an outside hospital. The aneurysm was
excluded with a bifurcated endograft device (Van-
guarde, 28/12/153, Boston Scientific, Oakland, NJ,
USA) with limbs that terminated in the common iliac
arteries. No endoleak was seen on the completion
angiogram (Fig. 1). The discharge summary described
an uneventful postoperative course. Fifteen months
following the stent graft deployment a right-sided
hemicolectomy for an adeno-carcinoma (pT3pN0cM0)
was carried out.
An X-ray four and a half years after the primary
procedure revealed, a stent graft dislocation caused by
ongoing proximal aneurysmal neck widening, with
elongation of the aneurysm so that there was distal
iliac stent migration with left-sided leg kinking (Fig.
2(a)). A proximal cuff (Vanguarde) was inserted with
a left-sided iliac limb crossing the internal iliac artery
(Fig. 2(b)). Because the intra-operative angiogram
showed a stenosed common femoral artery, right-
sided perfusion was restored by a graft from the
external iliac artery to the common femoral artery.
Before discharge a self-limiting lymphatic leak in the
right groin was diagnosed.
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One month later, the patient was admitted to
another hospital because of recurrent episodes of
fever, progressive body-weight loss, and low back
and abdominal pain. Laboratory test results showed
anaemia (haemoglobin 8.5 mg/dl) and a marked
elevation of C-reactive protein (CRP) concentration
(17.6 mg/dl), an increased ESR (112 mm/h), and a
serum creatinine level of 180 mmol/l. The CT scan was
interpreted as normal with a thrombosed aneurysmal
sac around the endovascular stent graft, without
specific sign of a graft infection. A radioactive white
cell scan with (740 MBq Tc99m) showed increased
activity corresponding to the region of the stent graft
prosthesis, especially the tortuous iliac limbs (Fig. 3).
Blood cultures grew Serratia marcescens sensitive to
ciprofloxacin. As treatment progressed the pyrexia
settled and CRP decreased to 1.6 mg/dl. The patient
was transferred to our care 3 weeks later, still on
ciprofloxacin.
He was weak, ill-looking and poorly nourished,
weighing 58 kg, with a tender abdomen. His tempera-
ture was 37.6 8C, and the CRP was 169 mg/dl, without
a leukocytosis. Further blood cultures still grew
Serratia marcescens. Antibiotic treatment was changed
to Piperacillin and Combactam, because resistance to
Ciprofloxacin had developed.
A new CT-scan was performed, which showed a
rapidly enlarging para-renal aortic segment, which
had increased in size from 4 to 6 cm over the 4 week
interval (Fig. 4(a) and (b)). A decision was made to
carry out surgical correction because of the risk of
rupture of the para-renal aortic aneurysm and the
stent graft prosthesis infection.
The aorta was exposed using medial visceral
rotation via a left para-median incision. Inflammation
surrounded the aneurysm wall at the level of the renal
arteries. The aorta was exposed right up to the celiac
trunk for proximal control. The superior mesenteric
artery, both renal arteries and the left-sided renal vein
were dissected free and then the external iliac arteries
were exposed for distal control. After proximal and
distal cross clamping, the aneurysm wall was opened.
No endoleak was observed. The proximal part of the
aortic stent graft main body and the proximal
extension cuff were surrounded by clot. The main
body of the stent graft prosthesis could be removed
easily; the proximal extension cuff was also not
incorporated and was effortlessly extracted. The
excised stent graft struts were intact, and there was
no evidence of damage to the fabric. The iliac graft
limbs were removed with some difficulty, because the
iliac arteries were tortuous and the iliac leg extensions
were oversized.
The aortic bed was debrided followed by an in situ
aortic replacement with a Rifampicin-impregnated
Dacron aortic tube graft. Flow was restored to the
superior mesenteric artery and the right-sided renal
artery using a common ostial patch anastomosis,
whereas the left-sided renal artery was reconstructed
with an aorto-renal bypass with a 6 mm ePTFE tube
graft. Finally an omental patch was fashioned to cover
the anastomoses. Culture from the aortic material and
the stent graft both grew Serratia marcescens, sensitive
to Piperacillin and Combactam, which were continued
for 12 days.
Postoperatively, the patient made a prolonged
recovery. Renal function was unaffected and the gut
worked well without any hints of altered perfusion.
The patient was about to be discharged from ICU to
the regular care ward on the twelfth postoperatively
day, when he developed sudden acute coronary
syndrome and died.
Discussion
In conventional open aortic surgery graft infection is a
well recognized but relatively uncommon compli-
Fig. 1. Completion angiogram of primary procedure.
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cation. The prevalence of primary graft infection is
about 1.3%, while that of secondary graft infection due
to enteric fistula amounts to 1.6%.7 The reported
mortality rate due to aortic graft infections lies
between 9 and 88%, while the amputation rate is up
to 27%, and aortic stump blowout occurs in up to 22%
of the cases. The one year survival rate is between 55
and 77%.1 – 3 The subject has been of great interest with
numerous reports dealing with epidemiological data
with long-term follow-up available,4,6 – 8 and even
more reports dealing with the therapeutic options
are published.
In contrast, infectious complications in connection
with endovascular aneurysm repair are not often
reported with respect to the 160,000 implants that
have been sold worldwide.
Our systematic bibliographic review using MEDLI-
NE/PubMed at the US National Library of Medicine
using the key words ‘infection’, ‘stent graft prosthesis’,
and ‘endovascular aneurysm repair’ documented an
increasing number of reports of infectious compli-
cations of endoluminal grafting with 28 patients with
stent graft infections being documented. The interval
between the primary procedure and the treatment of
Fig. 2. (a) X-ray examination (54 months post-procedural) with left-sided iliac leg kinking (arrow). (b) X-ray examination
following proximal and distal stent cuff deployment.
Fig. 3. 740 MBq 99mTc—labeled granulocytes-antibody scan.
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Table 1. Summary of reported aortic stent graft infections (bibliographic search: ‘infection’, ’stent graft prosthesis’, ‘endovascular aneurysm repair’)
Authors Year Lit. Prosthetic
infection
Graft-enteric
fistula
Device Interval Bacterial specimens Final outcome
Kolvenbach
et al.
1997 24 1 0 Stentor 14 Staphylococcus aureus Death (in hospital)
Norgren et al. 1998 26 0 1 Stentor 17 ? 6 months
Hausegger
et al.
1999 27 0 1 Vanguard 20 ? 6 months
Heikkinen
et al.
1999 21 1 0 Vanguard 3 Listeria monocytogenes 10 months
Makar et al. 2000 16 0 1 Zenith 4 ? Death (in hospital)
Mita et al. 2000 22 1 0 Dacron/Z-stent
(homemade)
2 ? ?
Chuter et al. 2000 17 0 1* Dacron/Z-stent
(homemade)
8 Staphylococcus aureus ? months, well
Janne d’Othee
et al.
2000 28 0 1 Stentor 22 Escherichia coli, Streptococcus milleri 40 months, well
Schlensak et al. 2001 11 4 1 Stentor (2),
Vanguard (3)
7, 17, 23,
30, 56
E. coli (fistula), sterile (others) ?
Matsumura
et al.
2001 9 0 1 Excluder 1 S. aureus ?
Parry et al. 2001 29 0 1 AneuRx 6 Klebsiella oxytoca, Enterocossus sp. 7 monthss, well
Ohki et al. 2001 25 0 2 ?? 9, 30 ? Death
Jackson et al. 2002 12 1 0 Ancure 4 Enterococcus faecalis Death after 3 weeks in the
rehabilitation facility
Eliason et al. 2002 10 1 0 Ancure 4 Staphylococcus epidermidis (type-I-endoleak
coiling)
?
Baker et al. 2002 15 1 0 Talent 12 Vancomycin hydrochloride-sensitive
enterococcus
6 months, well
Dattilo et al. 2002 18 2 0 ?? 18, 32 Methicillin resistant S. aureus/? ?
Kar et al. 2002 30 0 1 AneuRx 24 Polymicrobial (Eikenella corrodens, Streptococcus
viridans, Fusobacterium spp., Prevotella spp.)
12 months, well
Speziale et al. 2002 13 1 0 Excluder 7 Listeria gravi/Murrayi ? months, well
Alankar et al. 2003 20 0 1 AneuRx 5 Enterococcus specimens 6 months, well
Abou-
Zamzam et al.
2003 19 0 1 Ancure 11 Staphylococcal and Streptococcal sp. 4 months, well
Clouse et al. 2003 23 1 0 EVT/Guidant AI
device
? ? ? months, infection has remained
indolent
Nichol et al. 2003 14 1 0 Talent 42 Negative 12 months, well
*Used to treat graft-enteric fistula as primary procedure.
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the infection was a median of 14 months, with a range
of 1–60 months (mean ^ SD: 17.8 ^ 15.7) (Table 1).
Several routes for the bacteria to gain access to the
graft are possible, with a direct route in the case of an
aortoenteric fistula. Mechanical properties associated
with proximal type-I-endoleak and stent graft defor-
mation due to aneurysmal neck kinking might be risk
factors in developing aortoenteric fistula with conse-
quent infections. Moreover, skin contamination during
secondary trans-femoral stent graft or during inter-
ventional procedures, which occur in up to 10–
20%,9 – 11 and hematogenous graft seeding12 – 14 may
occur. In this case, contamination from a groin wound
infection at the initial operation cannot be ruled out.12,
11 Finally, it might be speculated that bacteraemia
during the bowel resection procedure may have led to
a late infection.
Therapeutic strategies for stent graft prosthetic
infections have been dealt with in a similar way to
graft infections following conventional open aneur-
ysm repair. Even though, following systemic antibiotic
therapy, removed stent grafts have sometimes been
found to be sterile,15 the use of long-term antibiotics
usually fails,16 as in the present case.
Complete graft removal including the debridement
of infectious peri-aortic tissue is the preferred treat-
ment. The restoration of the aorto-iliac route is a
controversial issue, with either an axillofemoral
bypass procedure followed by excision of the infected
graft,15,17 – 19 or an orthotopic revascularisation after
the excision.20 Following stent graft prostheses
removal, in situ autogenous aortic reconstruction
with cryo-preserved allografts and/or superficial
femoral-popliteal vein (SFPV) or heterolog prostheses
(bifurcated rifampicin-impregnated Dacron graft or
PTFE) has been performed.10,12,14,20,21 As an additional
manoeuvre, the in situ prosthesis may be wrapped in
retroperitoneal and omental tissue.20,21
Outcome after conversion to open repair is not clear.
There are missing data in 11 reported cases,9 – 11,18,22,23
and in addition to our own case, another five lethal
outcomes have been reported.12,16,24,25 In 11 cases, the
infections were controlled and the patients followed
an uneventful postoperative course with a median
follow-up of 6.5 months (range 4–40; mean ^ SD:
10.9 ^ 10.6).
In conclusion, stent graft infection seems to be rare,
but is probably underrepresented in the literature,
with only 28 cases documented. Skin contamination
during stent graft insertion or transfemoral interven-
tional procedures require sterile handling, and it
seems reasonable to give prophylactic antibiotics not
only during stent graft deployment, but also in case of
secondary intervention. Prophylactic antibiotics
should be given if the patient requires another
unrelated operation to prevent hematogenous bac-
terial graft seeding. If stent graft infection is suspected,
the therapeutic strategies are similar to those in graft
infections following conventional aneurysm repair.
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